The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri;Ocena stȩżenia i przydatności diagnostycznej wybranych cytokin hematopoetycznych w osoczu chorych na raka endometrium i ze zmianami łagodnymi (miȩśniakami) macicy

Polski Merkuriusz Lekarski

Volumn 28, Issue 167, 2010, Pages 354-358

  ŁAwicki, SŁawomir ^a,b,c   Grazyna Bedkowska E W A ^a,b   Gacuta Szumarska, E W A ^a,b   Czygier, Malgorzata ^a,b   Szmitkowski, Maciej ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Biochemical Diagnostics ^*  (Poland)

^c Samodzielny Publiczny Dzieci cy Szpital Kliniczny   (Poland)

Author keywords

Endometrial cancer; Hematopoietic growth factors (hgfs); Tumour markers

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; ENDOMETRIUM TUMOR; FEMALE; HUMAN; LEIOMYOMA; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; LEIOMYOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954003704     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Baiocchi G., Kavanagh J. J., Talpaz M. i wsp.: Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer., 1991, 67, 990-996.
2. Bȩdkowska E., Ławicki S., Szmitkowski M.: Markery przydatne w diagnostyce i monitorowaniu raka endometrium i szyjki macicy. Post. Hig. Med. DOŚW., 2007, 61, 122-128.
3. Boran A., Solaroglu A., Tulunay G. i wsp.: The value of CA 125 levels in endometrial cancer. Int J. Gynecol. Cancer., 2004, 14, 1-7.
4. Ebert A.D., Wechselberger C., Martinez-Lacaci I. i wsp.: Expression of function of EGF-related peptides and their receptors in gynecological cancer- from basic science to therapy. J. Recept Signal Transduct Res., 2000, 20, 1-46.
5. Elmore L.W., Domson K., Moore J.R. i wsp.: Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Arch. Pathol. Lab. Med.. 2001, 125, 146-151.
6. Espinoza I., Beck A.H., Lee Ch-H., Zhu S., Montgomery K.D., Marinelli R.J., Ganjoo K.N., Nielsen T.O., Gilks C.B., West R.B., Rijn M.: Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. Am. J. Pathol., 2009, 174, 2347-2356.
7. Ferdeghini M., Gadducci A., Prontera C. i wsp.: Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data. Anticancer Res., 1993, 13, 709-713.
8. Hashimoto I., Kodama J., Seki N. i wsp.: Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer. Br. J. Cancer., 2001, 85, 93-97.
9. Inoue M., Kyo S., Fujita M.: Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res., 1994, 54, 3049-3056.
10. Jeyarajah A.R., lnd T.E., Skates S. i wsp.: Serum CA 125 elevation and risk of clinical detection of cancer asymptomatic postmenopausal women. Cancer., 1999, 85, 2068-2072.
11. Kaciński B.M., Chambers S.K., Stanley E.R.: The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumour manner of neoplastic disease activity in endometrial carcinoma patients. Int. J. Radiat. Oncol. Biol. Physics., 1990, 19, 619-626.
12. Kimura T., Azuma C., Saji F. i wsp.: The biological effects of macrofagecolony-stimulating factor induced by progresion on growth and differentiation of endometrial adenocarcinoma cells. Int. J. Cancer., 1991, 9, 229-233.
13. Kozakiewicz B.: Nowotwory złośliwe narza̧du rodnego. Nowa Med., 2003, 122, 111-127.
14. Ławicki S., Bȩdkowska E., Gacuta-Szumarska E. i wsp.: Ocena stȩżeń i przydatności diagnostycznej czynnika wzrostu komórek pnia (SCF) oraz czynnika stymuluja̧cego kolonie makrofagowe (M-CSF) w osoczu pacjentek z rakiem endometrium. Przegla̧d Lek., 2007, 64, 987-990.
15. Ławicki S., Bȩdkowska E., Gacuta-Szumarska E. i wsp.: Ocena stȩżenia i przydatności diagnostycznej czynnika wzrostu komórek pnia (SCF) oraz czynnika stymulujacego kolonie makrofagowe (M-CSF) w osoczu chorych na raka szyjki macicy. Pol. Merk. Lek., 2008, 25, 38-42.
16. Ławicki S., Czygier M., Gacuta-Szumarska E. i wsp.: Stȩżenie i przydatność diagnostyczna czynnika stymuluja̧cego kolonie granulocytarne (G-CSF) i makrofagowe (M-CSF) w osoczu chorych na raka jajnika. Pol. Merk. Lek., 2006, 125, 465-468.
17. Ławicki S., Omyla J., Mroczko B. i wsp.: Stȩżienie w osoczu czynnika wzrostu kolonii makrofagowych (M-CSF) w przebiegu leczenia raka pierSi. Pol. Archiw. Med. Wew., 2004. 4, 1191-1197.
18. Lawicki S., Szmitkowski M., Wojtukiewicz M.: The pretreatment plasma level and diagnostic utility of M-CSF in benign tumor and breast cancer patients. Clin. Chim. Act., 2006, 371, 112-116. (Pubitemid 44162904)
19. Ławicki S., Bȩdkowska G.E., Gacuta-Szumarska E., Czygier M., Szmitkowski M.: The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri. Pol. Merk. Lek., 2009, 156, 609-615.
20. Menczer J., Kravtsov V., Levy T., Berger E., Glezerman M., Avinoach L: Expression of c-kit in uterine carcinosarcoma. Gynecol. Oncol. 2005, 96, 210-215.
21. Olt G., Soper J., Ramakrishnan S. i wsp.: Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer. Am. J. Obstet. Gynecol., 1996, 174, 1316-1319.
22. Osuga Y., Koga K., Tsutsumi O. i wsp.: Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis. A. J R. I., 2000, 44, 231-235.
23. Punnonen R., Teisala K., Kuoppala T. i wsp.: Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer., 1998, 83, 788-796.
24. Rutkowski P., Kamińska J., Kowalska M. i wsp.: Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int. J. Cancer., 2002, 100, 463-471.
25. Scholl S.M., Baseou C.H., Mosseri V.: Circulating levels of colony-stimulating factor 1 asa prognostic indicator in 82 patients with epithelial ovarian cancer. Br. J. Cancer., 1994, 69, 342-346.
26. Suzuki M., Ohwada M., Sato I. i wsp.: Serum level of macrophage colony-stimulating factor as a manner for gynecologic malignancies. Oncology, 1995, 52, 128-133.
27. Takeda S., Soutter W.P., Dibb N.J. i wsp.: Biological activity of the receptor for macrofage colony-stimulating factor in the human endometrial cancer cell line. Br. J. Cancer., 1996, 73, 615-619.